Cellectar Biosciences CLRB
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 2.54 | 3 | -95.25 | -6 | -43.33 | 11 |
| 2025Q4 | 2.95 | 9 | -64.05 | -5 | -35.77 | 15 |
| 2025Q3 | 5.6 | 8 | -63.12 | -4 | -31.38 | 15 |
| 2025Q2 | 7.11 | 6 | -75.99 | -5 | -36.64 | 14 |
| 2025Q1 | 9.46 | 8 | -58.58 | -7 | -31.81 | 16 |
| 2024Q4 | 8.97 | 14 | -15.99 | -2 | -7.5 | 25 |
| 2024Q3 | 64.2 | 15 | -106.48 | -15 | -43.99 | 37 |
| 2024Q2 | 75 | 12 | -7.39 | -1 | -2.54 | 29 |
| 2024Q1 | 119.4 | 13 | -27 | -96.91 | 43 | |
| 2023Q4 | 83.1 | -15 | -8 | -46.87 | 12 | |
| 2023Q3 | 79.2 | -13 | -13 | -93.84 | 22 | |
| 2023Q2 | 58.5 | 0 | -10 | -95.37 | 7 | |
| 2023Q1 | 42.9 | 7 | -75.13 | -9 | -47.11 | 15 |
| 2022Q4 | 51.3 | 16 | -51.06 | -7 | -35.27 | 22 |
| 2022Q3 | 100.8 | 13 | -47.42 | -8 | -34.55 | 19 |
| 2022Q2 | 121.14 | 20 | -31.37 | -7 | -25.69 | 26 |
| 2022Q1 | 206.34 | 27 | -20.38 | -6 | -17.75 | 32 |
| 2021Q4 | 199.2 | 33 | -16.52 | -6 | -14.95 | 37 |
| 2021Q3 | 277.5 | 39 | -14.1 | -6 | -12.98 | 42 |
| 2021Q2 | 357 | 44 | -12.86 | -6 | -11.73 | 48 |